Significant EU funding for international AICCELERATE consortium proposing a scalable AI tool for smart hospital
14.12.2020 10:39:49 EET | HUS | Press release
The AICCELERATE consortium consists of specialists in the fields of IT, machine learning, robotics, neurology, paediatrics and surgery from Finland, Italy, Spain, Turkey, Netherlands, Germany and Belgium.
Healthcare systems lack flexible AI solutions that allow hospitals to improve efficiency and the quality of patient care. Current solutions provide limited scalability and are confined to isolated applications. Scalable models that address data sharing, integration, privacy, and ethics are needed to ensure better adoption of AI in healthcare. Patient empowerment and evidence-based trust towards AI is a key part of the project. Evaluation activities will also focus on cost-benefit analysis of the AI-solutions.
AICCELERATE will develop partners’ existing digital solutions further to enable the development of a Smart Hospital Care Pathway (SHCP) Engine. This engine serves as a toolset for AI models and robotics to improve quality of care and health outcomes. It will also enable lean management and effective decision-making.
These tools are tested in three pilots that will provide feedback for improving the SHCP Engine: (i) patient flow management for ER and surgical units, (ii) digital care pathway for Parkinson’s disease, and (iii) paediatric service delivery.
The pilots are carried out by 5 hospital partners: Helsinki University Hospital and Oulu University Hospital from Finland, Ospedale Pediatrico Bambino Gesù from Italy, Barcelona Children's Hospital from Spain, and University Hospital Università degli Studi di Padova from Italy.
In addition to these above mentioned hospitals The AICCELERATE consortium is formed by Erasmus Univ. Rotterdam from Netherlands, RTO Fundació Eurecat from Spain, a Spanish non-profit TICBioMed, 6 SMEs aiming to advance the digitalization of the European healthcare services: Chino from Italy, Symptoma from Austria, Nuromedia from Germany, SRDC from Turkey, Evondos from Finland, NeuroPath from Belgium, and 2 large enterprises NEC Laboratories Europe from Germany and Innofactor from Finland. The preparation of the proposal was supported by Spinverse from Finland.
Keywords
Contacts
More information:
Development Manager Tuuli Pajunen
tuuli.pajunen@hus.fi, +358 40 182 5028
Research and Innovation Manager Suzan Ikävalko,
suzan.ikavalko@hus.fi, +358 50 583 4292
Images
About HUS
At HUS Helsinki University Hospital about 680 000 patients receive medical care annually. We have almost 27,000 professionals working for the best of all patients. We are responsible for providing specialized health care for the residents of our 24 member municipalities. In addition, the treatment of many rare and severe diseases is nationally centralized to HUS.
HUS is the biggest health care provider and the second largest employer in Finland. Our expertise is internationally recognized and accredited. As a university hospital, we continuously develop and evaluate our treatment methods and activities.
Subscribe to releases from HUS
Subscribe to all the latest releases from HUS by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from HUS
Terapeutisk balans för långtidssjuka unga bevaras vid övergången till vuxensidan9.4.2026 08:37:05 EEST | Pressmeddelande
En nyligen färdigställd studie visar att övergången från den specialiserade sjukvården för barn till tjänster för vuxna gick bra för största delen av långtidssjuka unga. I synnerhet positiva vårdupplevelser och en välplanerad övergångsprocess stöder bevarad terapeutisk balans. Psykisk hälsa har en viktigare roll i övergångsskedet än man tidigare känt till.
Pitkäaikaissairaiden nuorten hoitotasapaino säilyy hyvin siirryttäessä aikuispuolelle9.4.2026 08:37:05 EEST | Tiedote
Vasta valmistunut tutkimus osoittaa, että pitkäaikaissairaiden nuorten siirtyminen lasten erikoissairaanhoidosta aikuisten palveluihin sujuu suurella osalla hyvin. Erityisesti myönteiset hoitokokemukset ja huolellisesti suunniteltu siirtymäprosessi tukevat hoitotasapainon säilymistä. Psyykkisellä hyvinvoinnilla on aiemmin tiedettyä merkittävämpi rooli siirtymävaiheessa.
Disease control in young people with chronic conditions remains stable during transition to adult healthcare9.4.2026 08:37:05 EEST | Press release
A recently completed study shows that the transition of young people with chronic conditions from pediatric specialized healthcare to services for adults goes well for most of them. Positive experiences of care and a carefully planned transfer process in particular support the stability of disease control. Mental wellbeing plays a more important role in the transition phase than previously known.
Hjärnaneurysmens läge förutsäger dödligheten vid en hjärnblödning8.4.2026 08:38:10 EEST | Pressmeddelande
En internationell studie under ledning av HUS neurokirurgi avslöjade att hjärnaneurysmens läge har en betydande inverkan på prognosen för en livshotande hjärnblödning. I synnerhet rupterade aneurysm i bakre delen av skallen är förknippade med en stor risk för plötslig död.
Aivovaltimon pullistuman sijainti ennustaa aivoverenvuodon kuolleisuutta8.4.2026 08:38:10 EEST | Tiedote
HUSin neurokirurgian johtama kansainvälinen tutkimus paljasti, että aivovaltimon pullistuman sijainti vaikuttaa merkittävästi hengenvaarallisen aivoverenvuodon ennusteeseen. Erityisesti kallon takaosan puhjenneisiin aneurysmiin liittyy suurin äkkikuolemariski.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom